These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 2484147)

  • 1. [Blood lipids and the clinical state of hormone-treated women during menopause].
    Dominiczak-Gawrońska M
    Ann Acad Med Stetin; 1989; 35():145-66. PubMed ID: 2484147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood pressure and hemodynamics in postmenopausal women during estradiol-17 beta substitution.
    Luotola H
    Ann Clin Res; 1983; 15 Suppl 38():1-121. PubMed ID: 6367617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of the climacteric symptomatology modifications and clinical-instrumental parameters in women in physiological menopause treated with hormone replacement therapy with nomegestrol acetate and in surgical menopause treated with estrogen replacement therapy. Part I].
    Savoca S; D'Agosta S; Lombardo G
    Minerva Ginecol; 2007 Jun; 59(3):205-14. PubMed ID: 17576399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hormone replacement therapy with 17 beta-estradiol dydrogesterone: results of a 3-month open-label study].
    Grisar J; Travica S; Metka M; Pietschmann P
    Wien Klin Wochenschr; 1999 Dec; 111(24):1035-43. PubMed ID: 10677891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in lipoproteins with various sex steroids.
    Teran AZ; Greenblatt RB; Chaddha JS
    Obstet Gynecol Clin North Am; 1987 Mar; 14(1):107-19. PubMed ID: 3306515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
    Stanosz S; Zochowska E; Safranow K; Sieja K; Stanosz M
    Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical effects of 17 beta-estradiol and norethisterone acetate in postmenopausal Thai women.
    Limpaphayom KK; Bunyavejchevin S
    J Med Assoc Thai; 2000 Apr; 83(4):407-16. PubMed ID: 10808701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormone therapy in women in the menopause transition. Randomised, double-blind, placebo-controlled trial of effects on body weight, blood pressure, lipoprotein levels, antithrombin III activity, and the endometrium.
    Khoo SK; Coglan MJ; Wright GR; DeVoss KN; Battistutta D
    Med J Aust; 1998 Mar; 168(5):216-20. PubMed ID: 9539899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endocrine and metabolic effects of low-dose estrogen-progestin treatment in climacteric women.
    Ylöstalo P; Kauppila A; Kivinen S; Tuimala R; Vihko R
    Obstet Gynecol; 1983 Dec; 62(6):682-6. PubMed ID: 6355937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of oral tibolone 1.25 or 2.5 mg/day vs. placebo in postmenopausal women.
    Hudita D; Posea C; Ceausu I; Rusu M
    Eur Rev Med Pharmacol Sci; 2003; 7(5):117-25. PubMed ID: 15214586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The neurovegatative reaction-situation in climacteric. Modification of blood pressure regulation by estrogens].
    Carol W; Krepler S; Hempel E; Klinger G
    Zentralbl Gynakol; 1976; 98(9):546-53. PubMed ID: 936820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and short-term effects of pravastatin, a potent inhibitor of HMG-Co A reductase, on hypercholesterolemia in climacteric women.
    Ushiroyama T; Ikeda A; Ueki M; Sugimoto O
    J Med; 1994; 25(5):319-31. PubMed ID: 7730737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Acupuncture against climacteric disorders? Lower number of symptoms after menopause].
    Wyon Y; Lindgren R; Hammar M; Lundeberg T
    Lakartidningen; 1994 Jun; 91(23):2318-22. PubMed ID: 8057708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hormone replacement therapy in women with arterial hypertension in peri- and postmenopause: hemodynamic effects].
    Bystrova MM; Britov AN; Gorbunov VM; Lebedev AV; Eliseeva NA; Smetnik VP; Slasten OP
    Ter Arkh; 2001; 73(10):33-8. PubMed ID: 11763512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Low-dose estrogens in the treatment of the climacteric syndrome].
    Kolarov G; Nalbanski B; Kamenov Z; Protich M; Obretsova M; Sirakov M
    Akush Ginekol (Sofiia); 1998; 37(4):1-4. PubMed ID: 10360038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Femal, a herbal remedy made from pollen extracts, reduces hot flushes and improves quality of life in menopausal women: a randomized, placebo-controlled, parallel study.
    Winther K; Rein E; Hedman C
    Climacteric; 2005 Jun; 8(2):162-70. PubMed ID: 16096172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Transcutaneous estradiol treatment in the climacteric].
    Pedersen OD; Jensen HK
    Ugeskr Laeger; 1990 Sep; 152(36):2561-4. PubMed ID: 2402844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Role of imbalance of sex hormones and gonadotropins in the development and course of essential hypertension in women].
    Liusov VA; Evsikov EM; Rudakov AV; Toropova TM; Leonova LN; Semikolenov AA
    Ross Med Zh; 1992; (3):5-9. PubMed ID: 1322746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
    Petersen KR
    Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of combined conjugated estrogen-medrogestone replacement therapy on lipid profiles, climacteric symptoms and the endometrium].
    Belaisch J; Nappi C; Affinito P; De Gezelle H; Botelho M; Oliveira HM; Martinez-Oliveira J; Gonzaga F
    J Gynecol Obstet Biol Reprod (Paris); 2000 Feb; 29(1):29-40. PubMed ID: 10675831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.